We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 61-80 of 10,000 results
  1. Bidirectional Mendelian randomization analysis of the genetic association between primary lung cancer and colorectal cancer

    Background

    With the development and popularization of low-dose chest CT technology, the diagnosis and survival rates of patients with early lung...

    Zhihan **ao, Zichen Wang, ... Mingxuan Si in Journal of Translational Medicine
    Article Open access 15 October 2023
  2. Antineoplastic Effects of Curcumin Against Colorectal Cancer: Application and Mechanisms

    Curcumin is one of the major bioactive metabolites of turmeric, a spice component common in southeast Asia. Curcumin is known for its...
    Vivek Kumar Soni, Arundhati Mehta, ... Naveen Kumar Vishvakarma in Colon Cancer Diagnosis and Therapy Vol. 3
    Chapter 2022
  3. Inherited BRCA1 and RNF43 pathogenic variants in a familial colorectal cancer type X family

    Genetic susceptibility to familial colorectal cancer (CRC), including for individuals classified as Familial Colorectal Cancer Type X (FCCTX),...

    James M. Chan, Mark Clendenning, ... Daniel D. Buchanan in Familial Cancer
    Article Open access 08 December 2023
  4. Optimized screening of DNA methylation sites combined with gene expression analysis to identify diagnostic markers of colorectal cancer

    Background

    The prognosis of patients with colorectal cancer is related to early detection. However, commonly used screening markers lack sensitivity...

    Zhen Ye, Guangle Song, ... Hanming Jiang in BMC Cancer
    Article Open access 03 July 2023
  5. Randomised phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab (RAM) versus trifluridine/tipiracil for previously treated patients with advanced gastric or esophagogastric junction adenocarcinoma (RETRIEVE study, WJOG15822G)

    Background

    Trifluridine/tipiracil (FTD/TPI) prolongs survival in the third- or later-line treatment for advanced gastric cancer (GC), esophagogastric...

    Naoki Takahashi, Hiroki Hara, ... Kei Muro in BMC Cancer
    Article Open access 05 August 2023
  6. A Japanese case of ovarian mucinous adenocarcinoma with germline double variants of MSH2 and BRCA2

    Germline double heterozygosity (GDH) is rarely reported in cases of inherited cancer syndromes, and GDH of a mismatch repair gene and BRCA has never...

    Rina Harada, Hiroyuki Matsubayashi, ... Masakuni Serizawa in Journal of Human Genetics
    Article 07 July 2023
  7. New insights into macrophage polarization and its prognostic role in patients with colorectal cancer liver metastasis

    Background

    As liver metastasis is the most common cause of mortality in patients with colorectal cancer, studying colorectal cancer liver metastasis...

    Isha Khanduri, Harufumi Maki, ... Dipen M. Maru in BJC Reports
    Article Open access 26 April 2024
  8. The depth of perineural invasion is an independent prognostic factor for stage II colorectal cancer

    Background

    Perineural invasion (PNI) is the invasion of nerves by cancer cells and is associated with poor survival in stage II colorectal cancer....

    Hao Chen, Chao Wang, ... **aosheng He in BMC Cancer
    Article Open access 08 April 2024
  9. MALAT1-related signaling pathways in colorectal cancer

    Colorectal cancer (CRC) is one of the most lethal and prevalent solid malignancies worldwide. There is a great need of accelerating the development...

    Wen-Wen Xu, ** **, ... Maryam Farzaneh in Cancer Cell International
    Article Open access 19 March 2022
  10. Novel biomarker SARIFA in colorectal cancer: highly prognostic, not genetically driven and histologic indicator of a distinct tumor biology

    SARIFA (Stroma AReactive Invasion Front Areas) has recently emerged as a promising histopathological biomarker for colon and gastric cancer. To...

    Nic G. Reitsam, Veselin Grozdanov, ... Bruno Märkl in Cancer Gene Therapy
    Article Open access 22 November 2023
  11. Genome-wide polygenic risk scores for colorectal cancer have implications for risk-based screening

    Background

    Hereditary factors, including single genetic variants and family history, can be used for targeting colorectal cancer (CRC) screening, but...

    Max Tamlander, Bradley Jermy, ... Nina Mars in British Journal of Cancer
    Article Open access 03 January 2024
  12. METTL3 recruiting M2-type immunosuppressed macrophages by targeting m6A-SNAIL-CXCL2 axis to promote colorectal cancer pulmonary metastasis

    Background

    The regulatory role of N6-methyladenosine (m6A) modification in the onset and progression of cancer has garnered increasing attention in...

    Peng Ouyang, Kang Li, ... Zhen Bao in Journal of Experimental & Clinical Cancer Research
    Article Open access 11 April 2024
  13. Aspirin increases chemosensitivity of colorectal cancer cells and inhibits the expression of toll-like receptor 4

    Background

    Chemotherapy resistance is an important bottleneck affecting the efficacy of chemotherapy in colon cancer. Therefore, improving the...

    Jun Ying, Haiyang Zhou, ... Jian Zhang in Cancer Cell International
    Article Open access 16 January 2023
  14. Plasma cell signatures predict prognosis and treatment efficacy for lung adenocarcinoma

    Purpose

    This study aims to identify key genes regulating tumor infiltrating plasma cells (PC) and provide new insights for innovative immunotherapy....

    Long Shu, Jun Tang, ... Yongguang Tao in Cellular Oncology
    Article 09 October 2023
  15. Establishment of disulfidptosis-related LncRNA signature as biomarkers in colon adenocarcinoma

    Purpose

    Metabolic reprogramming is a hallmark of cancer and plays a key role in precision oncology treatment. Long non-coding RNAs (lncRNAs) regulate...

    Hongfei Yao, Peng Liu, ... **ao Li in Cancer Cell International
    Article Open access 27 May 2024
  16. Interaction of lncRNAs with mTOR in colorectal cancer: a systematic review

    Colorectal cancer (CRC) is the third most widespread cancer and the fourth leading lethal disease among different societies. It is thought that CRC...

    Marziyeh Sadat Moslehian, Roya Shabkhizan, ... Ebrahim Sakhinia in BMC Cancer
    Article Open access 06 June 2023
  17. TGFβ signalling pathway impacts brain metastases profiles in locally advanced colorectal cancer

    Rationale

    Colorectal Cancer (CRC) represents the third most common type of cancer in Germany and the second most common cancer-related cause of death...

    Sven Jacob, Ilja Balonov, ... Jens Neumann in Clinical & Experimental Metastasis
    Article Open access 18 March 2024
  18. Associations of IFT20 and GM130 protein expressions with clinicopathological features and survival of patients with lung adenocarcinoma

    Background

    Lung cancer is the leading cause of malignancy-related mortality and lung adenocarcinoma accounts for about 40% of lung malignancies. The...

    Lianfeng Li, Yaobing Chen, ... Lingzhi Qin in BMC Cancer
    Article Open access 22 July 2022
  19. STK11 loss leads to YAP1-mediated transcriptional activation in human KRAS-driven lung adenocarcinoma cell lines

    Serine Threonine Kinase 11 (STK11) loss of function (LoF) correlates with anti-PD-1 therapy resistance in patients with KRAS-driven lung...

    Sean M. Lenahan, Hailey M. Sarausky, ... David J. Seward in Cancer Gene Therapy
    Article Open access 15 November 2023
  20. Detection of (pre)cancerous colorectal lesions in Lynch syndrome patients by microsatellite instability liquid biopsy

    Lynch syndrome (LS) is an inherited condition characterized by an increased risk of develo** cancer, in particular colorectal cancer (CRC)....

    Mattia Boeri, Stefano Signoroni, ... Marco Vitellaro in Cancer Gene Therapy
    Article Open access 09 February 2024
Did you find what you were looking for? Share feedback.